Multiple sclerosis experts discuss data from four presentations on ozanimod, a disease modifying therapy that was presented at EAN 2022.
EP. 1: Brain and Cognitive Changes in Multiple Sclerosis
Dr DeLuca provides an overview of changes in cognition and brain volume loss in patients with multiple sclerosis.
EP. 2: Association Between Brain Volume and Long-term Cognition in Relapsing Multiple Sclerosis
Multiple sclerosis expert, Dr DeLuca, shares study design and clinical data on the association between brain volume and long-term cognition in patients with relapsing MS.
EP. 3: Cognitive Care Recommendations
Dr DeLuca shares his advice and recommendations from National MS Society on providing cognitive care for patients suffering from MS.
EP. 4: Factors Necessitating Treatment Change in Multiple Sclerosis
A multiple sclerosis expert, Dr Gabrielle Macaron, discusses factors that can lead to a change of therapy for patients with multiple sclerosis.
EP. 5: Ozanimod in DMT Naïve vs Experienced Patients with Relapsing Multiple Sclerosis
Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.
EP. 6: Clinical Pearls for MS Management in Everyday Practice
Dr Macaron shares her interpretation of the data and importance of individualizing treatment for patients with multiple sclerosis.
EP. 7: Treatment Discontinuation in Multiple Sclerosis
Dr Wallace Brownlee discusses reasons of and clinical impact of treatment discontinuation in multiple sclerosis.
EP. 8: Relapse Following Discontinuation of Ozanimod
A multiple sclerosis expert, Dr Brownlee shares study design and clinical data on relapse following discontinuation of ozanimod in patients with multiple sclerosis.
EP. 9: Implications of Ozanimod Discontinuation Data for MS Care
Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.
EP. 10: Managing Relapses in Patients With Multiple Sclerosis
Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.
EP. 11: Long-Term Outcomes With Ozanimod Based on Number of MS Relapses
A multiple sclerosis expert, Dr Darin Okuda reviews long-term outcomes with ozanimod in DAYBREAK trial based on the number of relapses that was presented at EAN 2022.
EP. 12: Advice for Clinical Management of Multiple Sclerosis
Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.
2 Clarke Drive Cranbury, NJ 08512